<--- Back to Details
First PageDocument Content
Clinical research / Food and Drug Administration / Pharmaceuticals policy / Clinical pharmacology / United States Public Health Service / Center for Veterinary Medicine / Regulatory requirement / Abbreviated New Drug Application / Health Canada / Pharmaceutical sciences / Pharmacology / Health
Date: 2012-05-16 15:54:19
Clinical research
Food and Drug Administration
Pharmaceuticals policy
Clinical pharmacology
United States Public Health Service
Center for Veterinary Medicine
Regulatory requirement
Abbreviated New Drug Application
Health Canada
Pharmaceutical sciences
Pharmacology
Health

May 10, 2012 RCC Agriculture and Food 2 Working Group: Veterinary Drugs Work Plan Canada Leads: Paul Glover, Assistant Deputy Minister, Health Products and Food Branch, Health Canada (HC) U.S. Leads: Murray Lumpkin, Com

Add to Reading List

Source URL: actionplan.gc.ca

Download Document from Source Website

File Size: 32,58 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document